The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document
  • ClinVar Id was derived from the Allele Registry.


Variant: NM_000261.2:c.752T>C

CA343726262

1342196 (ClinVar)

Gene: MYOC
Condition: juvenile open angle glaucoma
Inheritance Mode: Autosomal dominant inheritance
UUID: 4c28aa89-61ff-4446-8824-3254caef54d3
Approved on: 2022-02-21
Published on: 2022-07-11

HGVS expressions

NM_000261.2:c.752T>C
NC_000001.11:g.171636688A>G
CM000663.2:g.171636688A>G
NC_000001.10:g.171605828A>G
CM000663.1:g.171605828A>G
NC_000001.9:g.169872451A>G
NG_008859.1:g.20946T>C
ENST00000037502.11:c.752T>C
ENST00000637303.1:c.235-1942A>G
ENST00000638471.1:c.*90T>C
ENST00000037502.10:c.752T>C
ENST00000614688.1:c.752T>C
NM_000261.1:c.752T>C
NM_000261.2(MYOC):c.752T>C (p.Val251Ala)

Likely Pathogenic

Met criteria codes 5
PS2_Moderate PM2_Supporting PP3 PP1_Strong PS4_Supporting
Not Met criteria codes 10
BA1 BP7 BP4 BS3 BS1 PM6 PS1 PS3 PM5 PM4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Glaucoma Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Glaucoma VCEP
The c.752T>C variant in MYOC is a missense variant predicted to cause substitution of Valine by Alanine at amino acid 251 (p.Val251Ala). This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles. The REVEL score = 0.839, which met the ≥ 0.7 threshold for PP3, predicting a damaging effect on MYOC function. 17 segregations in 3 families with juvenile or primary open angle glaucoma (JOAG or POAG), have been reported (PMIDs: 32937162, 23517641 and Pasutto pers. comm.), which fulfilled PP1_Strong (≥ 7 meioses in >1 family). 3 probands with JOAG or POAG have been reported carrying this variant (PMIDs: 32937162, 23517641 and Pasutto pers. comm.), which met PS4_Supporting (≥ 2 probands). One of these was a confirmed de novo proband with JOAG (PMID: 23517641) (PS2_Moderate). In summary, this variant met the criteria to receive a score of 9 and to be classified as likely pathogenic (likely pathogenic classification range 6 to 9) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): PP1_Strong, PS2_Moderate, PP3, PS4_Supporting, PM2_Supporting.
Met criteria codes
PS2_Moderate
1 confirmed de novo proband with JOAG has been identified.
PM2_Supporting
This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles.
PP3
The REVEL score = 0.839, which met the ≥ 0.7 threshold for PP3, predicting a damaging effect on MYOC function.
PP1_Strong
17 segregations in 3 families, with juvenile or primary open angle glaucoma (JOAG or POAG), have been reported (PMIDs: 32937162, 23517641 and Pasutto pers. comm.), which fulfilled PP1_Strong (≥7 meioses in >1 family).
PS4_Supporting
3 probands with JOAG or POAG have been reported (PMIDs: 32937162, 23517641 and Pasutto pers. comm.) carrying this variant, which met PS4_Supporting (≥ 2 probands).
Not Met criteria codes
BA1
This criterion was not met as PM2_Supporting has been met.
BP7
This is not a synonymous or non-coding variant.
BP4
This criterion was not met as PP3 has been met.
BS3
No functional evidence has been found for this variant.
BS1
This criterion was not met as PM2_Supporting has been met.
PM6
This criterion was not met as PS2 has been met.
PS1
An established pathogenic variant causing this same amino acid change has not been identified.
PS3
No functional evidence has been found for this variant.
PM5
No other missense variants at this amino acid residue have been identified.
PM4
This variant does not cause a protein length change.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.